Magellan Diagnostics is recalling 11,442 LeadCare II Blood Lead Test Kits because the plastic caps on the treatment reagent tubes may not seal properly. This defect can lead to the evaporation or leaking of hydrochloric acid (HCl), which changes the chemistry of the test and can cause falsely high lead level results. These kits are used for measuring lead in capillary blood samples and were distributed nationwide across the United States.
Defective tube caps may cause the reagent to evaporate or leak, resulting in an incorrect ratio of patient blood to testing liquid. This chemical imbalance can trigger a false positive or an inaccurately high lead reading, which could lead to unnecessary medical treatments or follow-up procedures for patients.
Healthcare provider or manufacturer consultation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.